Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 409-420 of 1,740
Other study type icon
CompletedNCT01721720

Genetic, Brain Structure, and Environmental Effects on ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about ADHD.

ADHDObservationalA study where researchers collect information without assigning a treatment.Over 3 Years
Countries
United States
Sponsor
National Human Genome Research Institute (NHGRI)
Condition
ADHD
Drug study icon
CompletedNCT03250013

Long-term Effects of Medication for ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Gothenburg
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.From 6 Years to 17 Years
Countries
Sweden
Sponsor
Göteborg University
Condition
ADHD
Drug study icon
CompletedNCT00307684

Safety study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in ADHD

This study is completed in France, in Switzerland, in Germany, .... It is testing Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate for ADHD.

Multiple locations, including Paris
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 65 Years
Countries
France, Switzerland, Germany, ...
Sponsor
Janssen-Cilag International NV
Condition
ADHD
Drug study icon
CompletedNCT00202605

Safety and Efficacy of SPD465 in Adults With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Drug study icon
CompletedNCT02547428

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Newport Beach
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.